Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PTCT
|
Emily Luisa Hill
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 541 Reduced 2.27% |
$30,815
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Mark Elliott Boulding
EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct | 778 Reduced 1.58% |
$44,315
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct | 973 Reduced 2.64% |
$55,422
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect | 28 Reduced 1.52% |
$1,595
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Eric Pauwels
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 362 Reduced 0.98% |
$20,620
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,968 Reduced 2.39% |
$112,097
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 283 Reduced 1.84% |
$16,120
$56.96 p/Share
|
Feb 01
2021 |
|
PTCT
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct | 506 Reduced 1.81% |
$28,822
$56.96 p/Share
|
Feb 01
2021 |
|
PFSI
|
Jeffrey Grogin
Chief Enterprise Ops Officer |
SELL
Open market or private sale
|
Direct | 11,469 Reduced 28.51% |
$669,675
$58.39 p/Share
|
Feb 01
2021 |
|
LBRT
|
Michael Stock
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 43,000 Reduced 2.9% |
$509,120
$11.84 p/Share
|
Feb 01
2021 |
|
PSMT
|
Robert E Price |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$943,000
$94.3 p/Share
|
Feb 01
2021 |
|
PSMT
|
Philanthropies Foundation Price |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.24% |
$943,000
$94.3 p/Share
|
Feb 01
2021 |
|
MGPI
|
Karen Seaberg |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 4.26% |
$577,400
$57.74 p/Share
|
Feb 01
2021 |
|
SDGR
|
Jennifer Daniel
EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct | 418 Reduced 5.88% |
$38,122
$91.2 p/Share
|
Feb 01
2021 |
|
RAMP
|
James F. Arra
PRESIDENT AND CCO |
SELL
Open market or private sale
|
Direct | 9,500 Reduced 6.76% |
$729,125
$76.75 p/Share
|
Feb 01
2021 |
|
AMPH
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct | 639 Reduced 0.86% |
$11,668
$18.26 p/Share
|
Feb 01
2021 |
|
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 67,166 Reduced 0.81% |
$1,489,742
$22.18 p/Share
|
Feb 01
2021 |
|
PING
|
Lauren Adrienne Romer
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.04% |
$30,140
$30.14 p/Share
|
Feb 01
2021 |
|
TSE
|
M&G Investment Management LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 0.04% |
$156,720
$52.24 p/Share
|
Feb 01
2021 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 7,472 Reduced 27.4% |
$404,385
$54.12 p/Share
|
Feb 01
2021 |
|
TNC
|
Chris Killingstad
Director |
SELL
Open market or private sale
|
Direct | 6,593 Reduced 4.33% |
$447,862
$67.93 p/Share
|
Feb 01
2021 |
|
INSW
|
Jeffrey Pribor
SVP & CFO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.67% |
$16,000
$16.0 p/Share
|
Feb 01
2021 |
|
AZZ
|
Bryan Lee Stovall
COO - Metal Coatings |
SELL
Open market or private sale
|
Direct | 87 Reduced 0.52% |
$4,253
$48.88 p/Share
|
Feb 01
2021 |
|
CDE
|
Casey M. Nault
SVP, GC & Secretary |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 15.18% |
$612,000
$12.24 p/Share
|
Feb 01
2021 |
|
CCF
|
Adam Chase
President/CEO |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.49% |
$102,120
$102.12 p/Share
|
Feb 01
2021 |
|
JOUT
|
Thomas F Pyle Jr
Director |
SELL
Open market or private sale
|
Direct | 2,981 Reduced 6.74% |
$323,826
$108.63 p/Share
|
Feb 01
2021 |
|
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 182 Reduced 0.59% |
$12,414
$68.21 p/Share
|
Feb 01
2021 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 8,249 Reduced 0.82% |
$550,291
$66.71 p/Share
|
Feb 01
2021 |
|
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 133 Reduced 0.52% |
$9,072
$68.21 p/Share
|
Feb 01
2021 |
|
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 163 Reduced 0.51% |
$11,118
$68.21 p/Share
|
Feb 01
2021 |
|
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 105 Reduced 0.48% |
$7,162
$68.21 p/Share
|
Feb 01
2021 |
|
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.48% |
$19,990
$19.99 p/Share
|
Feb 01
2021 |
|
RLMD
|
Charles J Casamento
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 13.67% |
$100,800
$33.6 p/Share
|
Feb 01
2021 |
|
TCX
|
Elliot Noss
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.92% |
$397,100
$79.42 p/Share
|
Feb 01
2021 |
|
CPSI
|
John B Douglas Jr |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.43% |
$31,200
$31.2 p/Share
|
Feb 01
2021 |
|
CPSI
|
David A Dye
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.38% |
$30,940
$30.94 p/Share
|
Feb 01
2021 |
|
AMRK
|
Thor Gjerdrum
President |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$645,800
$32.29 p/Share
|
Feb 01
2021 |
|
AKRO
|
Jonathan Young
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,055 Reduced 1.7% |
$90,306
$29.56 p/Share
|
Feb 01
2021 |
|
CBNK
|
Stephen N Ashman
Director |
SELL
Open market or private sale
|
Indirect | 2,400 Reduced 0.38% |
$36,168
$15.07 p/Share
|
Feb 01
2021 |
|
PRTHW
|
Sean Kiewiet
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.51% |
$74,000
$7.4 p/Share
|
Feb 01
2021 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 100.0% |
$109,600
$87.68 p/Share
|
Feb 01
2021 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$33,800
$1.69 p/Share
|
Feb 01
2021 |
|
MDLA
|
Borge Hald
Director |
SELL
Open market or private sale
|
Direct | 350,000 Reduced 18.45% |
$14,395,500
$41.13 p/Share
|
Feb 01
2021 |
|
MDLA
|
Borge Hald
Director |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 7.87% |
$8,232,000
$41.16 p/Share
|
Feb 01
2021 |
|
SFST
|
Anne S Ellefson
Director |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 19.49% |
$90,067
$40.03 p/Share
|
Feb 01
2021 |
|
NSC
|
Alan H. Shaw |
SELL
Open market or private sale
|
Indirect | 43 Reduced 100.0% |
$10,302
$239.58 p/Share
|
Feb 01
2021 |
|
SEER
|
Omid Farokhzad
CEO AND CHAIR |
SELL
Open market or private sale
|
Indirect | 775,910 Reduced 77.86% |
$49,774,628
$64.15 p/Share
|
Feb 01
2021 |
|
SEER
|
Omid Farokhzad
CEO AND CHAIR |
SELL
Open market or private sale
|
Direct | 313,369 Reduced 51.3% |
$20,102,622
$64.15 p/Share
|
Feb 01
2021 |
|
DDOG
|
Olivier Pomel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 117,400 Reduced 72.86% |
$12,055,806
$102.69 p/Share
|
Feb 01
2021 |
|
DDOG
|
Olivier Pomel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 247,528 Reduced 60.2% |
$25,517,661
$103.09 p/Share
|
Feb 01
2021 |